OFFitalia participates at the 2014 FAS health call, in association with the Ophthalmology Clinic of the University of Florence, Department of Pharmacy at the University of Pisa and at the Department of Engineering of the University of Siena, through the research project TOSCORETINA: New therapies for retinitis pigmentosa: a Tuscan networks from basic research to […]
It was held in Lecce, 25-27 June 2015, the international conference SICSSO (Italian Society for Stem Cells and Ocular Surface). The congress was attended by ophthalmologists from around the world and numerous ad relevant were the scientific activities carried our. OFFitalia, also in this important event, has characterized his scientific participation by presenting two works: […]
OFFitalia participates at the ophthalmology AICCER National Congress (Italian Association of Cataract and Refractive Surgery) through a symposium entitled: “INNOVATION IN THE TREATMENT OF DRY EYE” The symposium was led by panelist of great depth, specialists of the ocular surface. The event was attended by more than 200 ophthalmologists from all over Italy, demonstrating the […]
OFFitalia is an Italian company strongly addressed to the research and the development of innovative healthcare solutions. And ‘from OFFitalia research and development laboratories is born the first drops in the world based on cross-linked hyaluronic acid. iCross, this is the brand of the product, is a real innovation in the field of diseases and […]
